VINCRISTINE HOSPIRA Solution for injection Ref.[8340] Active ingredients: 22-Oxovincaleukoblastine

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2018  Publisher: Hospira UK Limited, Horizon, Honey Lane, Hurley, Maidenhead, SL6 6RJ, UK

Product name and form

Vincristine Sulfate 1 mg/ml solution for injection.

Pharmaceutical Form

Solution for injection.

A sterile, colourless solution.

Qualitative and quantitative composition

Each 1 ml contains 1 mg of vincristine sulfate.

Each 2 ml contains 2 mg of vincristine sulfate.

For the full list of excipients, see section 6.1.

Active Ingredient Description
22-Oxovincaleukoblastine

Vincristine is an antineoplastic drug with broad-spectrum anti-tumor activity in man. The drug may act by mitotic inhibition, causing an arrest of cell division in metaphase.

List of Excipients

Mannitol
Water for injections

Pack sizes and marketing

2 ml Type I clear glass vials, with rubber closures and aluminium caps in packs of 5 vials.

2 ml Type I clear Onco-Tain vials, with rubber closures and aluminium caps in packs of 5 vials.

2.25 ml Type I clear glass, graduated, barrel syringes with luer lock as a single syringe pack.

Not all pack sizes may be marketed.

Marketing authorization holder

Hospira UK Limited, Horizon, Honey Lane, Hurley, Maidenhead, SL6 6RJ, UK

Marketing authorization dates and numbers

PL 04515/0008

9th November 2007

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.